Alurar da ke samar da kariya daga tetanus, diphtheria, da kuma pertussis (coughing cough) ba sababbin ba.
DTP, bayanan, ya kasance tun daga 1948 da DTaP tun 1997. Kuma kafin wadannan maganin rigakafi , mun sami maganin alurar rigakafi kan wadannan cututtuka na rigakafi .
Mene ne sabon game da Tdap shine wadannan maganin rigakafi sun bada kariya ga yara da tsofaffi.
Tdap Alurar riga kafi
Boostrix shine ƙwayoyin Tdap na farko wanda FDA ta amince.
Irin wannan magani na Tdap, Adacel, an amince da shi nan da nan bayan haka.
Boostrix da Adacel sun haɗa da toxoid tetanus (T), toxoid mai rage diphtheria (d) da maganin alurar rigakafi (ap) a cikin guda guda.
Tare, waɗannan maganin rigakafi sun ba matasa damar samun kariya, kuma baya kare su daga tetanus da diphtheria. Fayil da FDA ta ba su shine sanannen saƙo ga iyaye da yara masu jin dadin rayuwa game da karuwa a cikin annobar cutar ta pertussis a cikin 'yan shekarun nan.
A cewar FDA, '' Pertussis wata cututtuka ne mai ƙari ta hanyar respiratory wanda zai iya zama mai matukar muhimmanci ga jarirai a kasa da shekara guda, kuma yana iya zama m. Kwayar cutar ba ta da mawuyacin hali a matasan, amma ana tsammanin cewa zasu iya yada cutar zuwa ga jarirai da sauran 'yan uwa.
A cikin shekaru 20 da suka gabata, yawancin kamuwa da ƙwayoyin cuta da aka samu a cikin ƙananan yara sun karu sosai a kananan yara wadanda ba su sami dukkanin maganin rigakafi da matasa da kuma manya ba. "
Wane ne yake Bukatan Tarin Ciki
Yara za su yi farin ciki da jin cewa amincewa da sabon maganin ba shi da ma'anar cewa suna buƙatar samun karin harbi.
Maimakon haka, shi ya maye gurbin Td (mai girma tetanus) wanda sun riga sun karbi lokacin da suke shekaru 11 ko 12.
Magunin Tdap:
- za a iya ba wa yara a cikin shekaru 7 zuwa 10 idan ba a maganin rigakafi tare da sauran maganin alurar rigakafi ba, kamar DTaP
- an kuma bada shawara ga manya tsakanin shekarun 19 da 64 a matsayin lokaci ɗaya, wanda ya maye gurbin daya daga cikin shekaru 10 na TD boosters.
- zai iya taimaka maka kewaye da sabon jariri tare da kariya daga pertussis, wanda shine dalilin da ya sa samun jariri a gida yana da babban lokaci ga manya don samun samfurin Tdap (tsarin kulawa na kariya)
- ya kamata a bai wa tsofaffi a shekarun da suka kai 65 idan suna da alaka da ɗan jariri ko jariri kasa da 12 watanni (kuma wani ɓangare na kyakkyawan tsari na cocooning)
- za a iya ba wa tsofaffi a cikin shekaru 65 don maye gurbin daya daga cikin shekaru 10 na TD boosters
Kuma mafi mahimmanci, dole ne a ba wa mata masu juna biyu alurar rigakafin Tdap a lokacin kowane ciki.
Abin da ya sani game da maganin Talla
Wasu abubuwa da za su sani game da maganin Tdap sun hada da cewa:
- suna da kyauta marasa mahimmanci (wanda ke nufin cewa, kamar sababbin maganin alurar riga kafi, basu dauke da thimerosal)
- an yi tare da yawancin antigens iri daya da suke cikin maganin Infanrix DTaP da yawa yara sun riga sun samu
- lokaci mafi kyau don samun Tdap lokacin da kake ciki yana tsakanin makonni 27 da 36 na gestation don taimakawa "kara karfin maganin cutar ganyayyaki na haihuwa da kuma mikiyar canzawa zuwa ga jariri"
- ya kamata a ba shi nan da nan idan ba a ba shi ba a lokacin daukar ciki
- mai yiwuwa yana samar da "kariya mai kyau a kan pertussis a farkon shekara ta farko sannan kuma ya ci gaba da sauri don kariya kadan ya kasance shekaru 2-3 bayan rigakafin."
Kuma ko da yake magungunan Tdap ba su aiki kamar yadda muke so ba, suna aiki. Ɗaya daga cikin binciken ya ƙaddara cewa "Magunguna da maganin alurar riga kafi sun rage yawan rashin lafiyar da ke fama da rashin lafiya mai tsanani kuma yana rage yawan lokacin rashin lafiya."
Samun ilimi kuma ka sa yara su yi alurar riga kafi da kuma kare su daga tari, da kuma tetanus, diphtheria, da sauran cututtuka na rigakafi.
> Sources:
> Barlow RS. Yara da yara masu rigakafi da ciwo na cututtuka da ƙananan cututtuka sun rage yawan rashin lafiya da tsawon lokaci, Oregon, 2010-2012 Clin Infect Dis. 2014 Yuni; 58 (11): 1523-9.
> CDC. Shawarar da aka yi da shawarar don amfani da Tetanus Toxoid, Rage Cutar Toxoid Diphtheria, da Vaccine Aiki na Acellular (Tdap) a cikin Mata masu ciki - Shawarar Shawara kan Dokar Taimakon Lissafi (ACIP), 2012. MMWR 2013; 62 (07): 131-5.
> CDC. FDA Tabbatar da Ƙwararriyar Ƙwararren Ƙwararruwar Ƙwararrun Ƙwararruwa, Ƙarƙashin ƙwayar ƙwayar ƙwayar cuta da ƙwayar cutar ta Acellular Vaccine. MMWR. Satumba 23, 2011/60 (37); 1279-1280
> Klein, Nicola P. Waning Tdap Yin Aminci a Ado. Pediatrics. Volume 137, lamba 3, Maris 2016